A Multi-Site, Prospective, Non-Randomized Study of the Contura™ Multi-Lumen Balloon (MLB) Catheter to Deliver Accelerated Partial Breast Irradiation: Analysis of Dosimetry, Local Tumor Control, Cosmetic Outcome, and Toxicity
The Cancer Center of Irvine is one of the busiest centers in the United States for Contura
accelerated partial breast irradiation.
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Maximum total skin dose is less than or equal to 125% of the prescribed radiation dose.
19 months
Yes
Kenneth M Tokita, MD
Principal Investigator
Cancer Center of Irvine
United States: Institutional Review Board
S07-002
NCT00882596
May 2008
December 2014
Name | Location |
---|---|
Cancer Center of Irvine | Irvine, California 92618 |